Fibrocell Science was founded in 1995 and is headquartered in Exton, US

Report incorrect company information

President and Chief Executive Officer

Vice President of Regulatory Affairs and Quality Assurance

Vice President of Business Administration and Corporate Secretary

Report incorrect company information

Fibrocell Science has an office in Exton

Exton, US (HQ)

405 Eagleview Boulevard

Report incorrect company information

Fibrocell Science's revenue was reported to be $355 k in FY, 2016 which is a **27.8% decrease** from the previous period.

USD | |
---|---|

## Net income (Q2, 2017) | (14 m) |

## EBIT (Q2, 2017) | (5 m) |

## Market capitalization (5-Feb-2018) | 9.8 m |

## Cash (3-Feb-2018) | 15.9 m |

Fibrocell Science's current market capitalization is $9.8 m.

Annual

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|---|

## Revenue | 200 k | 180 k | 492 k | 355 k |

| (10%) | 173% | (28%) | |

## Cost of goods sold | 722 k | 697 k | ||

## Gross profit | (230 k) | (342 k) |

Quarterly

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|

## Revenue | 194 k | 137 k | 79 k | 16 k | 87 k | 215 k | ||||||

## Cost of goods sold | 1.9 m | 793 k | 547 k | 512 k | 147 k | 162 k | 204 k | 18 k | 392 k | 287 k | ||

## Gross profit | 47 k | (25 k) | (125 k) | (2 k) | (305 k) | (72 k) | ||||||

| 24% | (18%) | (158%) | (12%) | (351%) | (33%) |

Annual

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|---|

## Cash | 60 m | 37.5 m | 29.3 m | 17.5 m |

## Inventories | 1.2 m | 1.3 m | 1.2 m | |

## Current Assets | 61.9 m | 39.3 m | 31 m | 18 m |

Quarterly

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|

## Cash | 16.9 m | 54 m | 49.5 m | 44.2 m | 33.3 m | 26.9 m | 36.9 m | 13.1 m | 8.2 m | 21.3 m | 20.6 m | 15.9 m |

## Inventories | 574 k | 506 k | 476 k | 610 k | 544 k | 484 k | 566 k | 475 k | 109 k | |||

## Current Assets | 19.2 m | 55.5 m | 50.7 m | 45.3 m | 34.9 m | 28.1 m | 38 m | 14.6 m | 8.9 m | 21.7 m | 21.1 m | 16.4 m |

## Total Assets | 26.3 m | 62.4 m | 57.4 m | 51.9 m | 41.2 m | 34.1 m | 43.9 m | 20.2 m | 10.5 m | 23.2 m | 22.7 m | 18 m |

Annual

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|---|

## Net Income | (30.6 m) | (25.7 m) | (34.5 m) | (15.3 m) |

## Depreciation and Amortization | 863 k | 883 k | 767 k | 564 k |

## Inventories | (120 k) | 26 k | 35 k | 126 k |

## Accounts Payable | 2 m | (1.8 m) | (114 k) | (139 k) |

Quarterly

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|

## Net Income | (25 m) | (14 m) | (16.3 m) | (22.3 m) | (8.5 m) | (15.3 m) | (1.5 m) | (1.4 m) | (8.1 m) | (2.3 m) | (5 m) | (19 m) |

## Depreciation and Amortization | 693 k | 222 k | 452 k | 673 k | 140 k | 346 k | 91 k | 184 k | ||||

## Inventories | (97 k) | 91 k | 121 k | (13 k) | 27 k | 87 k | 566 k | 475 k | ||||

## Accounts Payable | 248 k | (2.1 m) | (1.6 m) | (1.9 m) | 774 k | 833 k | 2.6 m | 893 k | 553 k | 361 k | (55 k) | 192 k |

USD | Y, 2017 |
---|---|

## Financial Leverage | -5.2 x |

Report incorrect company information